1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one
C23H19ClF3NO4S2 — CID 162119513
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one
1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one (PubChem CID 162119513) has the molecular formula C23H19ClF3NO4S2 and a molecular weight of 529.99 g/mol. Its IUPAC name is 1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one.
Molecular Properties
| Compound Name | 1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one |
|---|---|
| PubChem CID | 162119513 |
| Molecular Formula | C23H19ClF3NO4S2 |
| Molecular Weight | 529.99 g/mol |
| Exact Mass | 529.04 |
| IUPAC Name | 1-[(2S)-1-(5-chlorothiophen-2-yl)sulfonylazetidin-2-yl]-3-[4-[3-(trifluoromethyl)phenoxy]phenyl]propan-1-one |
| SMILES | O=C(CCc1ccc(Oc2cccc(C(F)(F)F)c2)cc1)[C@@H]1CCN1S(=O)(=O)c1ccc(Cl)s1 |
| InChI | InChI=1S/C23H19ClF3NO4S2/c24-21-10-11-22(33-21)34(30,31)28-13-12-19(28)20(29)9-6-15-4-7-17(8-5-15)32-18-3-1-2-16(14-18)23(25,26)27/h1-5,7-8,10-11,14,19H,6,9,12-13H2/t19-/m0/s1 |
| InChIKey | ZHFLCKIBZKCDRE-IBGZPJMESA-N |
| XLogP | 6.18 |
| TPSA | 63.68 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 529.99 |
| LogP ≤ 5 | 6.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162119513 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.